(1 - 30 von 63
)
ArcherDX and Illumina Partner for Future to Co-Market CNNwww.cnn.com › business › newsfeeds › prnewswire
edition.cnn.com
· ... to patients," said Dr. Phil Febbo, Chief Medical Officer of Illumina and follow us @ArcherDXInc on Twitter, Facebook and LinkedIn.
OptimizeRx Continues Coronavirus Conversation Series with CNNwww.cnn.com › newsfeeds › globenewswire
edition.cnn.com
He will be joined by Rusty Frantz, president and CEO of NextGen, and Phil Febbo, chief medical officer and SVP of Illumina. The panel will be moderated by ...
Test aids prostate cancer treatment | Fox News
www.foxnews.com
... and previous research linking a poor response to the two drugs to the AR-V7 variant, are sufficient validation for clinical use, said Phil Febbo, ...
Dr. Phil Febbo Named to Varian Board of Directors - PR...
news.boardprospects.com
Dr. Phil Febbo Named to Varian Board of Directors
Weill Cornell Medicine, NewYork-Presbyterian Hospital, and ...
www.finanzen.net
Dec 03, · "Working together to deploy whole-genome sequencing as a front-line test in an American healthcare system is truly trailblazing," said Phil Febbo, senior vice president and chief medical officer ...
Illumina : Names Dr. Phil Febbo Chief Medical Officer | MarketScreener
www.marketscreener.com
Brings unmatched bench-to-bedside expertise to catalyze the adoption of precision medicine | March 12,
Illumina names Dr. Phil Febbo Chief Medical Officer - Borderless
www.borderless.net
Illumina, Inc. announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March ...
Phil Febbo | 360Dxwww.360dx.com › people-news
www.360dx.com
Illumina has appointed Phil Febbo as chief medical officer. Starting March 26, 2018, Febbo will be responsible for developing and executing on Illumina's ...
Varian Medical : Dr. Phil Febbo Named to Varian Board of Directors |...
www.marketscreener.com
PALO ALTO, Calif., Aug. 21, PRNewswire/ -- Varian today announced that Phil Febbo, MD, chief medical officer at Illumina has been appointed to the...
Varian Medical Systems (VAR) Appoints Dr. Phil Febbo to Board
www.streetinsider.com
Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of ...
Dr. Phil Febbo - DOTmedwww.dotmed.com › news › story
www.dotmed.com
· PALO ALTO, Calif., Aug. 21, PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at ...
Illumina Names Dr. Phil Febbo Chief Medical Officerwww.illumina.com › news-center › press-releases
www.illumina.com
· (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March ...
PierianDx kündigt erweiterte Partnerschaft mit Illumina zur...
www.onvista.de
Zusätzliche Illumina-Assays sollen mit der PierianDx-Plattform verknüpft werden, um Zeit, Kosten und Komplexität der genomischen Berichterstellung zu...
Dr. Phil Febbo Named to Varian Board of Directors
www.lelezard.com
Varian today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, ...
Genomic Health : Oncotype DX® Predicts 10-year Risk of Developing...
www.marketscreener.com
March 29, Oncotype DX® Predicts 10-year Risk of Developing Metastatic Prostate Cancer in Low- and Intermediate-risk Patients...
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
A radiation confederation | Drug Discovery News
www.drugdiscoverynews.com
Varian and Oncora partner to accelerate precision medicine in radiation oncology
Adaptive Biotechnologies Enters Partnership with Illumina to Develop...
investors.adaptivebiotech.com
Phil Febbo , Chief Medical Officer of Illumina . “We are committed to unlocking the power of the genome through our work with Adaptive which will ...
Africa news roundup: April - Research Professional Newswww.researchprofessionalnews.com › ...
www.researchprofessionalnews.com
“This donation will enable countries across Africa to deeply understand the circulating virus at scale,” said Phil Febbo, Illumina's chief medical ...
Home Page - Cypriot Biotech Database
www.cypriotbiotech.com
Twitter LinkedIn Google+ ... Phil Febbo, M.D., chief medical officer, Genomic Health and former professor of medicine and urology at the University of California, ...
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of...
www.boulderventures.com
Co-marketing partnership to drive awareness of ArcherDX IVD products and
increase access to vital genomic information in the community oncology care
setting
Genomic Health announces Medicare coverage for Oncotype DX prostate...
www.news-medical.net
... immediate aggressive treatment resulting in unnecessary surgery and radiation," said Phil Febbo, M.D., chief medical officer, Genomic Health ...
Home Page - Maltese Biotech Database
www.maltesebiotech.com
Twitter LinkedIn Google+ ... validation of genomic information can transform cancer treatment," said Phil Febbo, M.D., chief medical officer, Genomic Health.
Latest News - Taiwanese Life Sciences Database
www.taiwaneselifesciences.com
Twitter LinkedIn Google+ patient risk stratification and better informed treatment decisions," said Phil Febbo, M.D., chief medical officer, Genomic Health .
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of...
www.finanzen.ch
BOULDER, Colo., Jan. 10, PRNewswire/ -- ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ...
Genomic Frontiers Conference | Precision Medicine at UCSFprecisionmedicine.ucsf.edu › events › genomic-fron...
precisionmedicine.ucsf.edu
Phil Febbo, Chief Medical Officer, Illumina: Our genomic future(s); Sara Tishkoff, Director of the Center for Global Genomics and Equity at University of ...
Illumina appoints chief medical officer | S&P Global Market...
www.spglobal.com
Genetic testing services provider Illumina Inc. appointed Phil Febbo as chief medical officer, effective March 26. Febbo most recently served as chief medical ...
Illumina partners with Africa CDC to strengthen sequencing capacity...
africacdc.org
... can be used to help protect the health of the African population, and in turn, the world,” said Dr Phil Febbo, Illumina's Chief Medical Officer.
sortiert nach Relevanz / Datum